PROSTATE SPECIFIC ANTIGEN [PSA] AS EARLY DETECTION APPROACH FOR PROSTATE CANCER: SYSTEMIC REVIEW IN LITERATURE

被引：0

作者：

Alhussain, Zead ^{[1
]}

Alghamdi, Ali ^{[2
]}

Alamri, Husam ^{[3
]}

Alyami, Rawan ^{[4
]}

Alnamlah, Suliman ^{[3
]}

Mutaki, Ibrahiem ^{[5
]}

Alkhaldi, Samar ^{[6
]}

Mushni, Saad ^{[7
]}

Alelyani, Mohammad ^{[2
]}

Alamri, Khalid ^{[8
]}

机构：

[1] Arabian Gulf Univ, Coll Med, Manama, Bahrain

[2] Albaha Univ, Coll Med, Albaha, Bahrain

[3] Imam Mohammed Bin Saud Islamic Univ, Coll Med, Riyadh, Saudi Arabia

[4] Tabuk Univ, Coll Med, Tabuk, Saudi Arabia

[5] King Faisal Univ, Coll Med, Al Hasa, Saudi Arabia

[6] Taif Univ, Coll Med, At Taif, Saudi Arabia

[7] Imam Abdulrahman bin Faisal Univ, Coll Med, Dammam, Saudi Arabia

[8] King Khalid Univ, Coll Med, Abha, Saudi Arabia

来源：

INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2018年 / 5卷 / 11期

关键词：

prostate specific antigen; early detection; screening;

D O I：

10.5281/zenodo.1550856

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

This review is aiming to discuss the prostate Specific Antigen [PSA] As Early Detection Approach for Prostate Cancer. A systemic search for the terms: Prostate Cancer, prevention, methods for early detection and screening using prostate specific antigen [PSA] was done up to 2018 in the period between the first of September to the 6th of October in different databases including Google Scholar, Science Direct and NCBI including PubMed, Studies has been rated as being high quality by an established evaluation process based on the DyunaMed criteria and its levels of evidence. Out of the five trials and studies, only the PLCO trial concluded to the fact that the prostate cancer screening using the prostate specific antigen shows no evidence in reducing the mortality from the disease after the follow-up period. This review concluded to the importance of using the PSA as a screening tool in reducing prostate mortality although more researches need to be done.

引用

页码：13238 / 13244

页数：7

共 50 条

[1] Free and complexed prostate-specific antigen (PSA) in the early detection of prostate cancer
Tello, FL
Prats, CH
González, MDD
[J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (02) : 116 - 120
[2] A SYSTEMIC REVIEW OF COST-EFFECTIVENESS OF PROSTATE-SPECIFIC ANTIGEN (PSA) IN PROSTATE CANCER SCREENING
An, J. J.
Wu, J.
Huang, J. T.
Nichol, M. B.
[J]. VALUE IN HEALTH, 2010, 13 (03) : A38 - A38
[3] Prostate-specific antigen in the early detection of prostate cancer
Thompson, Ian M.
Ankerst, Donna P.
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2007, 176 (13) : 1853 - 1858
[4] Prostate-specific antigen and early detection of prostate cancer
Chu, TM
[J]. TUMOR BIOLOGY, 1997, 18 (02) : 123 - 134
[5] From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer
Hori, Satoshi
Blanchet, Jean-Sebastien
McLoughlin, John
[J]. BJU INTERNATIONAL, 2013, 112 (06) : 717 - 728
[6] Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
Filella, Xavier
Foj, Laura
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (11)
[7] Prostate cancer and prostate specific antigen (PSA) screening in Austria
Vutuc, C
Schernhammer, ES
Haidinger, G
Waldhör, T
[J]. WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (13-14) : 457 - 461
[8] Early detection of prostate cancer - Role of prostate-specific antigen
Prabhakaran, VM
[J]. CANADIAN FAMILY PHYSICIAN, 1996, 42 : 709 - 712
[9] Prostate-specific antigen testing for the early detection of prostate cancer
Fitzpatrick, J
[J]. BJU INTERNATIONAL, 2004, 94 (07) : 966 - 967
[10] Prostate specific antigen for early detection of prostate cancer: longitudinal study
Holmstrom, Benny
Johansson, Mattias
Bergh, Anders
Stenman, Ulf-Hakan
Hallmans, Goran
Stattin, Par
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 : 793

← 1 2 3 4 5 →